OCT 04, 2021 8:29 PM PDT

Guillain-Barre Syndrome After COVID-19 Infection

WRITTEN BY: Alexandria Bass

Researchers with the International GBS Outcome Study (IGOS) consortium investigated newly-diagnosed GBS patients from the beginning of the pandemic – January to March 2020 – to determine if there was an increased incidence of GBS related to SARS-CoV-2 infection. GBS cases have spiked in the past to the 1976 H1N1 swine flu vaccination and to the 2015 Zika virus pandemic.

Guillain-Barre is an autoimmune disease where progressive muscle weakness occurs as a result of immune destruction of nerves in the peripheral nervous system. There are different variants of GBS, with acute inflammatory demyelinating polyradiculoneuropathy (AIDP) being the most common form in the US. The AIDP variant involves sensory changes and symmetrical, rapidly progressive limb weakness that usually starts in the legs and moves upward, potentially paralyzing respiratory muscles. Other symptoms include numbness, tingling, and autonomic dysfunction that can cause cardiac arrhythmias and unstable blood pressures. 

Onset can occur after surgeries, medications, and gut and respiratory infections, such as infection with Campylobacter jejuni, Mycoplasma pneumoniae, Haemophilus influenzae, cytomegalovirus, and Epstein-Barr virus. Symptoms usually present around 3 weeks after infection and become most severe by 4 weeks from symptom onset. 

GBS is diagnosed through antibody testing for ganglioside antibodies, lumbar puncture for cerebrospinal examination, and electromyography and nerve conduction studies. Characteristic CSF findings include high protein levels with normal white blood cell counts.

Neurological conditions have been linked to COVID-19 infection. Other than the typical loss of sense of smell and taste, more serious neurological symptoms are strokes, changes in consciousness, and injury to the skeletal muscles. SARS-CoV-2 is thought to cause neurological symptoms by attaching to the ACE2 receptor present on nerve and muscle tissues.

In this international prospective observational cohort study, IGOS researchers did not detect an increase in GBS diagnosis during the first 4 months of the COVID-19 pandemic, suggesting GBS is not very likely to develop after COVID-19 infection. 

Of the 49 patients examined in the study, 8 had a confirmed and 3 had a probable COVID-19 infection before developing GBS symptoms, with no evidence of having had another recent infection that could explain the onset of GBS. COVID-19-related GBS cases were associated with a sensorimotor, demyelinating variant and with severe symptoms of GBS.
 

About the Author
  • Alexandria (Alex) is a freelance science writer with a passion for educating the public on health issues. Her other professional experience includes working as a speech-language pathologist in health care, a research assistant in a food science laboratory, and an English teaching assistant in Spain. In her spare time, Alex enjoys cycling, lap swimming, jogging, and reading.
You May Also Like
SEP 30, 2021
Clinical & Molecular DX
Stick-on Diagnostic Patch Inspired by Beetles
SEP 30, 2021
Stick-on Diagnostic Patch Inspired by Beetles
Schematic illustration of the adhesive patch with diving beetle–inspired suction chambers against rough and wet hu ...
OCT 03, 2021
Health & Medicine
Why Did a Town Start Putting People on Trial for Witchcraft?
OCT 03, 2021
Why Did a Town Start Putting People on Trial for Witchcraft?
In early 1692 in Salem, Massachusetts, the daughter and niece of Reverend Samuel Parris began to writhe, roar, contort, ...
OCT 08, 2021
Cannabis Sciences
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
OCT 08, 2021
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
As medical cannabis becomes legalized around the globe, patients need to explore which routes of cannabis delivery best ...
OCT 11, 2021
Genetics & Genomics
A Genetic Risk Factor is Shared by Alzheimer's and Severe COVID-19
OCT 11, 2021
A Genetic Risk Factor is Shared by Alzheimer's and Severe COVID-19
While amyloid plaques are a hallmark of Alzheimer's disease, the neurological disorder has also been linked to inflammat ...
OCT 17, 2021
Genetics & Genomics
Genes That Cause Disease Seem to Prevent Beneficial Adaptations
OCT 17, 2021
Genes That Cause Disease Seem to Prevent Beneficial Adaptations
A new study has used computational tools to investigate evolution in the human genome that's occurred over the past 50,0 ...
OCT 19, 2021
Cardiology
Can Optimism Save Lives?
OCT 19, 2021
Can Optimism Save Lives?
Throughout history, optimism has been viewed as a cornerstone of resilience. In the words of Helen Keller, optimism is t ...
Loading Comments...